Emma Guttman

Here's a condensed version under 250 words:

Emma Guttman-Yassky, MD, PhD, is the Waldman Professor of Dermatology and Immunology and Health System Chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, New York. She is Director of the Center of Excellence in Eczema, Director of the Laboratory for Inflammatory Skin Diseases, and Co-Director of the Mount Sinai Clinique Skin Aging Center.

Dr. Guttman earned her MD from the Sackler School of Medicine at Tel Aviv University and her PhD from Bar-Ilan University, Israel. After completing dermatology training in Israel, she pursued a postdoctoral fellowship at The Rockefeller University, followed by a second dermatology residency at Weill Cornell Medical College, where she obtained American board certification.

Her research focuses on atopic dermatitis (eczema), hair loss disorders, and skin aging. She has made paradigm-shifting discoveries defining the immunologic basis of atopic dermatitis in both adults and children, leading to the development of targeted therapies. Her work has also advanced the understanding and treatment of alopecia areata, scarring alopecia, chronic hand eczema, keloids, ichthyosis, and other inflammatory skin diseases.

Dr. Guttman co-founded the International Eczema Council and is its past president. She has received numerous national and international awards, delivered keynote and plenary lectures worldwide, and authored more than 475 peer-reviewed publications in leading medical journals.

David E. Fisher, MD, PhD, Chief of the Massachusetts General Hospital Department of Dermatology from 2008 to 2025, is the Edward Wigglesworth Professor of Dermatology Harvard Medical School. He also serves as director of Mass General’s Cutaneous Biology Research Center and director of its multidisciplinary Melanoma Center. A professor of dermatology and pediatrics at Harvard Medical School, Dr. Fisher came to MGH from the Dana-Farber Cancer Institute, where he previously directed the melanoma program. Dr. Fisher’s research has focused on understanding molecular and genetic events which underlie formation of melanoma and skin pigmentation. As a clinician, he has worked to translate these understandings into advances in diagnosis, treatment and prevention of human diseases related to skin and associated disorders. Dr. Fisher is a 2020 inductee into the National Academy of Medicine. In 2022 he was selected to Direct the Melanoma Academy run by the US Department of Defense. And in 2025 he was selected as Fellow of the American Academy of Cancer Research (FAACR).

He received his doctorate under Nobel Laureate Gunter Blobel and Henry Kunkel at Rockefeller University and his medical degree at Cornell Medical College. Dr. Fisher’s specialty training in Medicine, Pediatrics, Oncology were carried out at MGH, Dana-Farber, Boston Children’s, Brigham and Women’s. His research contributions include elucidation of the pathway through which UV radiation induces pigmentation, identification of MITF as master transcriptional regulator in melanocytes and melanoma oncogene, novel approaches to melanoma treatment and prevention, and discovery of the link between ultraviolet radiation and addictive behaviors.

Here's a condensed version under 250 words:

Emma Guttman-Yassky, MD, PhD, is the Waldman Professor of Dermatology and Immunology and Health System Chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, New York. She is Director of the Center of Excellence in Eczema, Director of the Laboratory for Inflammatory Skin Diseases, and Co-Director of the Mount Sinai Clinique Skin Aging Center.

Dr. Guttman earned her MD from the Sackler School of Medicine at Tel Aviv University and her PhD from Bar-Ilan University, Israel. After completing dermatology training in Israel, she pursued a postdoctoral fellowship at The Rockefeller University, followed by a second dermatology residency at Weill Cornell Medical College, where she obtained American board certification.

Her research focuses on atopic dermatitis (eczema), hair loss disorders, and skin aging. She has made paradigm-shifting discoveries defining the immunologic basis of atopic dermatitis in both adults and children, leading to the development of targeted therapies. Her work has also advanced the understanding and treatment of alopecia areata, scarring alopecia, chronic hand eczema, keloids, ichthyosis, and other inflammatory skin diseases.

Dr. Guttman co-founded the International Eczema Council and is its past president. She has received numerous national and international awards, delivered keynote and plenary lectures worldwide, and authored more than 475 peer-reviewed publications in leading medical journals.

Here's a condensed version under 250 words:

Emma Guttman-Yassky, MD, PhD, is the Waldman Professor of Dermatology and Immunology and Health System Chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, New York. She is Director of the Center of Excellence in Eczema, Director of the Laboratory for Inflammatory Skin Diseases, and Co-Director of the Mount Sinai Clinique Skin Aging Center.

Dr. Guttman earned her MD from the Sackler School of Medicine at Tel Aviv University and her PhD from Bar-Ilan University, Israel. After completing dermatology training in Israel, she pursued a postdoctoral fellowship at The Rockefeller University, followed by a second dermatology residency at Weill Cornell Medical College, where she obtained American board certification.

Her research focuses on atopic dermatitis (eczema), hair loss disorders, and skin aging. She has made paradigm-shifting discoveries defining the immunologic basis of atopic dermatitis in both adults and children, leading to the development of targeted therapies. Her work has also advanced the understanding and treatment of alopecia areata, scarring alopecia, chronic hand eczema, keloids, ichthyosis, and other inflammatory skin diseases.

Dr. Guttman co-founded the International Eczema Council and is its past president. She has received numerous national and international awards, delivered keynote and plenary lectures worldwide, and authored more than 475 peer-reviewed publications in leading medical journals.

Here's a condensed version under 250 words:

Emma Guttman-Yassky, MD, PhD, is the Waldman Professor of Dermatology and Immunology and Health System Chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, New York. She is Director of the Center of Excellence in Eczema, Director of the Laboratory for Inflammatory Skin Diseases, and Co-Director of the Mount Sinai Clinique Skin Aging Center.

Dr. Guttman earned her MD from the Sackler School of Medicine at Tel Aviv University and her PhD from Bar-Ilan University, Israel. After completing dermatology training in Israel, she pursued a postdoctoral fellowship at The Rockefeller University, followed by a second dermatology residency at Weill Cornell Medical College, where she obtained American board certification.

Her research focuses on atopic dermatitis (eczema), hair loss disorders, and skin aging. She has made paradigm-shifting discoveries defining the immunologic basis of atopic dermatitis in both adults and children, leading to the development of targeted therapies. Her work has also advanced the understanding and treatment of alopecia areata, scarring alopecia, chronic hand eczema, keloids, ichthyosis, and other inflammatory skin diseases.

Dr. Guttman co-founded the International Eczema Council and is its past president. She has received numerous national and international awards, delivered keynote and plenary lectures worldwide, and authored more than 475 peer-reviewed publications in leading medical journals.

James G. Krueger is Head of the Laboratory for Investigative Dermatology at The Rockefeller University in New York, NY, USA. He also serves as Physician and Co-director of the Center for Clinical and Translational Science at the Rockefeller University Hospital, and as Chief Executive Officer of the Rockefeller University Hospital.

Dr Krueger earned his Bachelor's degree from Princeton University (Princeton, NJ, USA) and a PhD degree in virology and cell biology from The Rockefeller University. He received his medical degree from Cornell University Medical College (New York City), where he also completed an internship in internal medicine and a residency in dermatology. Dr Krueger is certified by the American Board of Dermatology.

His research group at The Rockefeller University was the first to conduct clinical trials with specific, targeted immune antagonists in psoriasis and this work established that elimination of pathogenic Tcells from skin lesions could reverse the full pathological phenotype of psoriasis. Since then, his group has used immune-based therapeutics to dissect inflammatory pathways in psoriasis, Hidradenitis suppurativa (HS), and Atopic dermatitis (AD) as well as other inflammatory skin conditions, and to conduct parallel pharmacogenomic studies that define mechanisms of targeted therapeutics in human populations. Dr Krueger has been an advocate of bidirectional translational research (bench to bedside and back) in humans to dissect pathogenic pathways that cannot be studied in animal models, particularly for skin diseases.